Filing Details
- Accession Number:
- 0000878526-19-000136
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-12-09 18:05:49
- Reporting Period:
- 2019-12-06
- Accepted Time:
- 2019-12-09 18:05:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
878526 | Natus Medical Inc | NTUS | Electromedical & Electrotherapeutic Apparatus (3845) | 770154833 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1451629 | Jonathan Kennedy | C/O Natus Medical Incorporated 6701 Koll Center Parkway, Suite 120 Pleasanton CA 94566 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value Per Share | Acquisiton | 2019-12-06 | 7,600 | $22.50 | 148,441 | No | 4 | M | Direct | |
Common Stock, $0.001 Par Value Per Share | Disposition | 2019-12-06 | 6,684 | $31.54 | 141,757 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option | Disposition | 2019-12-06 | 6,684 | $0.00 | 6,684 | $22.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,240 | 2014-02-01 | 2020-01-01 | No | 4 | M | Direct |
Footnotes
- 1.This transaction was executed in multiple trades a prices ranging from $31.45 to $31.60. The price reflected above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.